Glenn Jaffe MD

Cataract Related, Retinal Disease, Uveitis

Professor, Ophthalmology, Duke University School of Medicine

2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Fax+1 919-681-6474

Dr. Jaffe is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jaffe's full profile Already have an account?

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1987 - 1989
University of California (San Francisco)Residency, Ophthalmology, 1984 - 1987
University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1983 - 1984
University of California San Francisco School of MedicineClass of 1983

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 1989 - 2027
WI State Medical License 1987 - 1989
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
COMPLETED
PHASE4
Retisert and Cataract Surgery in Patients With Severe Uveitis
COMPLETED
NA
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
COMPLETED
PHASE3

Publications & Presentations

PubMed

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.
Usha Chakravarthy, Chui Ming Gemmy Cheung, Giovanni Staurenghi, SriniVas Sadda, Robyn Guymer
Ophthalmology Science. 2026-08-01
Pooled Analyses of Anatomic and Visual Function Data of Revakinagene Taroretcel-lwey in Participants with Macular Telangiectasia Type 2.
Roger A Goldberg, Debora C Manning, Joanna Yankey, W Lloyd Clark, Muna I Bitar
Ophthalmology. Retina. 2026-07-20
1 citations
Standardizing Measurement of Complete Retinal Pigment Epithelial and Outer Retinal Atrophy: Classification of Atrophy Meeting Report 8.
David Sarraf, Federico Corvi, Philip J Rosenfeld, Thomas Ach, Barbara Blodi
Ophthalmology. Retina. 2026-06-01

Journal Articles

Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging
Frank Brodie, Natalie Afshari, Jennifer E Thorne, Albert Vitale, David Myung, Mark S Blumenkranz, Elmer Tu, David Sarraf, Glenn J Jaffe, Malvina Eydelman, JAMA Ophthalmology
Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial
Glenn Jaffe, MD, JAMA Ophthalmology

Press Mentions

First Academic Medical Center Implants Cell-Based Therapy for Rare Eye DiseaseOctober 28th, 2025
ARVO Foundation Announces Recipient of 2025 Oberdorfer Award in Low Vision ResearchMarch 10th, 2025
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve VisionNovember 4th, 2024